OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Published in:
2017
By:
- Bowyer, Samantha;
- Prithviraj, Prashanth;
- Lorigan, Paul;
- Larkin, James;
- McArthur, Grant;
- Atkinson, Victoria;
- Millward, Michael;
- Khou, Muoi;
- Diem, Stefan;
- Ramanujam, Sangeetha;
- Kong, Ben;
- Liniker, Elizabeth;
- Guminski, Alexander;
- Parente, Phillip;
- Andrews, Miles C;
- Parakh, Sagun;
- Cebon, Jonathan;
- Long, Georgina V;
- Carlino, Matteo S;
- Klein, Oliver
Publication type:
Letter
Residual FDG- PET metabolic activity in metastatic melanoma patients with prolonged response to anti- PD-1 therapy.
Published in:
Pigment Cell & Melanoma Research, 2016, v. 29, n. 5, p. 572, doi. 10.1111/pcmr.12503
By:
- Kong, Benjamin Y.;
- Menzies, Alexander M.;
- Saunders, Catherine A. B.;
- Liniker, Elizabeth;
- Ramanujam, Sangeetha;
- Guminski, Alex;
- Kefford, Richard F.;
- Long, Georgina V.;
- Carlino, Matteo S.
Publication type:
Article